U.S. Tells Glaxo to End Enrollment in Avandia Trial
Thursday, July 22, 2010 - 00:07
in Health & Medicine
The F.D.A. also ordered GlaxoSmithKline to inform the 1,324 people already testing two diabetes drugs that its product Avandia may increase heart risks.